Su Chao-Yue, Li Jing-Quan, Zhang Ling-Ling, Wang Hui, Wang Feng-Hua, Tao Yi-Wen, Wang Yu-Qing, Guo Qiao-Ru, Li Jia-Jun, Liu Yun, Yan Yan-Yan, Zhang Jian-Ye
The Fifth Affiliated Hospital, Key Laboratory of Molecular Target and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China.
The First Affiliated Hospital, Hainan Medical University, Haikou, China.
Front Pharmacol. 2020 Sep 11;11:579068. doi: 10.3389/fphar.2020.579068. eCollection 2020.
Integrins are the adhesion molecules and receptors of extracellular matrix (ECM). They mediate the interactions between cells-cells and cells-ECM. The crosstalk between cancer cells and their microenvironment triggers a variety of critical signaling cues and promotes the malignant phenotype of cancer. As a type of transmembrane protein, integrin-mediated cell adhesion is essential in regulating various biological functions of cancer cells. Recent evidence has shown that integrins present on tumor cells or tumor-associated stromal cells are involved in ECM remodeling, and as mechanotransducers sensing changes in the biophysical properties of the ECM, which contribute to cancer metastasis, stemness and drug resistance. In this review, we outline the mechanism of integrin-mediated effects on biological changes of cancers and highlight the current status of clinical treatments by targeting integrins.
整合素是细胞外基质(ECM)的黏附分子和受体。它们介导细胞-细胞以及细胞-ECM之间的相互作用。癌细胞与其微环境之间的相互作用引发了各种关键的信号线索,并促进了癌症的恶性表型。作为一种跨膜蛋白,整合素介导的细胞黏附对于调节癌细胞的各种生物学功能至关重要。最近的证据表明,肿瘤细胞或肿瘤相关基质细胞上存在的整合素参与ECM重塑,并且作为机械转导分子感知ECM生物物理特性的变化,这有助于癌症转移、干性和耐药性。在本综述中,我们概述了整合素介导对癌症生物学变化影响的机制,并强调了靶向整合素的临床治疗现状。